Vesalius Biocapital Partners

Summary

Vesalius Biocapital Partners appeared to be the VC, which was created in 2007. The company was established in Europe in Luxembourg. The main department of described VC is located in the Strassen.

The higher amount of exits for fund were in 2014. The fund is constantly included in 2-6 investment rounds annually. The usual things for fund are deals in the range of 5 - 10 millions dollars. Comparing to the other companies, this Vesalius Biocapital Partners performs on 9 percentage points less the average number of lead investments. The top activity for fund was in 2011. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Genkyotex, Promethera Biosciences, Tonic App For fund there is no match between the location of its establishment and the land of its numerous investments - Belgium. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Machine Learning, Biopharma.

Besides them, we counted 3 critical employees of this fund in our database.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Vesalius Biocapital Partners, startups are often financed by High-Tech Gru00fcnderfonds, VC Fonds Technologie Berlin, S.R.I.W.. The meaningful sponsors for the fund in investment in the same round are S.R.I.W., Limburgse Reconversie Maatschappij, High-Tech Gru00fcnderfonds. In the next rounds fund is usually obtained by SFPI-FPIM, S.R.I.W., Lumira Ventures.